MEDP · NASDAQ · Medical - Diagnostics & Research

Medpace (MEDP)

Runs integrated Phase I–IV trials and laboratory services for drug and device developers.

$630.14
vs last close+5.94 (+0.95%)
  1. Why Is Medpace (MEDP) Up 1.1% Since Last Earnings Report?

    Zacks Investment ResearchMarket move